Real-life outcomes of the PAUL® Glaucoma Implant with ripcord in refractory glaucoma

Key Points

• Positive outcomes were observed in patients receiving the PAUL® glaucoma implant, providing effective management of refractory glaucoma.
• Improvement metrics showed a reduction in intraocular pressure by an average of 20%, with over 60% of patients achieving desired outcomes.
• Assessment involved a retrospective cohort analysis of glaucoma patients with prior unsuccessful treatments across various clinics.
• These findings support the PAUL® implant as a promising intervention, suggesting further exploration in diverse patient populations.